News & Publications

NEWS & PUBLICATIONS

Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.


Prous Insitute is pleased to announce the launch of our new website showcasing the features and benefits of Symmetry, the world’s first integrated predictive platform for drug discovery and safety evaluation.  To visit the website please click here.   


Prous Institute for Biomedical Research is pleased to announce the publication of its new WIPO patent application: Pyrano[3,2-c][2]benzopyran-6(2H)-one derivatives and uses thereof.  Claimed  compounds have shown inhibitory activity against SGLT2 (type 2 sodium-glucose linked transporter) and have displayed positive effects in glycemia control in animal models. SGLT2 inhibitors promote t...


Compounds developed using Prous Institute Symmetry® Drug Discovery Platform open new avenues in cancer treatment Prous Institute for Biomedical Research has announced the recent publishing of its new WIPO patent application. The cited compounds figured among the new magnolol and honokiol derivatives obtained at the Prous Institute for Biomedical Research that have shown inhibitory activ...